# Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT).

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-and-biomarker-results-of-neoadjuvant-phase-ii-study-of-pembrolizumab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Priyanka Sharma,Shane R. Stecklein,Rachel Yoder,Joshua M. Staley,Kelsey Schwensen,Anne O’Dea,Lauren Nye,Manana Elia,Deepti Satelli,Gregory Crane,Rashna Madan,Maura O’Neil,Jamie L. Wagner,Kelsey E. Larson,Christa Balanoff,Milind A. Phadnis,Andrew K. Godwin,Roberto Salgado,Qamar J. Khan,Joyce O’Shaughnessy |
| Citations | 51 |
| DOI | 10.1200/jco.2022.40.16_suppl.513 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4281646658 |
| Type | conference-abstract |
| Year | 2022 |

## Paper authors

- [Milind A. Phadnis](https://scholariq.org/researchers/milind-a-phadnis/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.